Publications by authors named "Felix Dietlein"


Identification of cancer driver genes based on nucleotide context.

Nat Genet 2020 02 3;52(2):208-218. Epub 2020 Feb 3.

Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article and Find Full Text PDF
February 2020

Propranolol und Morbus Parkinson.

Nuklearmedizin 2018 02 21;57(1):1-3. Epub 2018 Feb 21.

View Article and Find Full Text PDF
February 2018

Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma.

Cell Rep 2017 Sep;20(12):2833-2845

Molecular Pathology, Institute of Pathology, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany; Department of Translational Genomics, Medical Faculty, University of Cologne, Weyertal 115b, 50931 Cologne, Germany; Center for Molecular Medicine Cologne, University of Cologne, 50931 Cologne, Germany. Electronic address:

View Article and Find Full Text PDF
September 2017

The tumour suppressor CYLD regulates the p53 DNA damage response.

Nat Commun 2016 08 26;7:12508. Epub 2016 Aug 26.

Institute for Genetics, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) and Centre for Molecular Medicine (CMMC), University of Cologne, Joseph-Stelzmann-Straβe 26, Cologne 50931, Germany.

View Article and Find Full Text PDF
August 2016

Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer.

Oncotarget 2015 Nov;6(36):38458-68

Department I of Internal Medicine, Center of Integrated Oncology Köln-Bonn, University of Cologne, Germany and Center of Molecular Medicine Cologne (ZMMK), University of Cologne, Cologne, Germany.

View Article and Find Full Text PDF
November 2015